Amyloid-Related Imaging Abnormalities With Donanemab in Early Symptomatic Alzheimer Disease

Post time 6 day(s) ago

journal：JAMA Neurology

Authors：Jennifer A. Zimmer; Paul Ardayfio; Hong Wang; Rashna Khanna; Cynthia D. Evans; Ming Lu; JonDavid Sparks; Scott Andersen; Steve Lauzon; Emel Serap Monkul Nery; Chakib Battioui; Staci E. Engle; Alessandro Biffi; Diana Svaldi; Stephen Salloway; Steven M. Greenberg; Reisa A. Sperling; Mark Mintun; Dawn A. Brooks; John R. Sims

Published date：2025-5-1

DOI：10.1001/jamaneurol.2025.0065

PDF link：https://jamanetwork.com/journals ... 746814093.91763.pdf

Article link：https://doi.org/10.1001/jamaneurol.2025.0065

Article Source：American Medical Association (AMA)。

Remark：

Post time 6 day(s) ago

: This post has been completed
Completed attachments will be deleted within 24 hours.

[JAMA] Amyloid-Related Imaging Abnormalities With Donanemab in Early Symptomatic Alzheimer Disease

Best Answer

Same Category

Latest Reply

Announcement

Daily Top Contributors

[JAMA] Amyloid-Related Imaging Abnormalities With Donanemab in Early Symptomatic Alzheimer Disease Copy